TUNGKOL SA EPISODE NA ITO

Ingles
Estados Unidos

KOPYA NG SALIN 🔗

I-SEARCH ANG MGA NAKARAANG EPISODE

I-search ang mga nakaraang episode ng The Dime.

IBA PANG MGA EPISOD SA PODCAST NA ITO

The cannabis industry convinced the world it had a medicine before the science caught up. Now the science is here, and almost no one is paying attention. CBD is not a panacea. When Charlotte's Web opened hearts and minds, the messaging of what it could do ran years ahead of what the data could act…
Cannabis rescheduling is not as simple as “Trump rescheduled cannabis.” States are interpreting rescheduling completely differently depending on their license structure. These tiny details are widening the gap between potential winners and losers. In this episode, we break down what actually chan…
The number in your head and the number you actually need are not the same number. That gap is where most cannabis businesses break. Joe Lustberg has financed operators across the country for years and watched that gap swallow businesses that looked fine on paper. He has also spent over two years p…
When a regulator asks what the downside is of adding one more testing requirement, what is the downside? Just a little more safe. Just in case. Especially when adding one more item to an already exhaustive testing panel. That logic is how licensed cannabis markets end up buried under compliance la…
Predictable cash flow is the whole game. In cannabis, predictable is the one thing almost nobody has. Organigram CEO James Yamanaka came up over 20 years at British American Tobacco, where that discipline is the entire model. He thinks the opportunity starts there: trim the portfolio, stop chasing…
Paunawa: Ang podcast at artwork na naka-embed sa page na ito ay mula sa Bryan Fields, na pag-aari ng may-ari nito at hindi kaakibat o ineendorso ng Listen Notes, Inc.